BA
JNJ icon

Bridgewater Associates’s Johnson & Johnson JNJ Stock Holding History

Bridgewater Associates’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$170M Sell
696,884
-617,074
-47% -$144M 0.76% 18
2025
Q4 		$272M Sell
1,313,958
-401,819
-23% -$79.5M 0.99% 15
2025
Q3 		$318M Sell
1,715,777
-566,762
-25% -$97.1M 1.25% 12
2025
Q2 		$349M Buy
2,282,539
+1,985,251
+668% +$305M 1.41% 11
2025
Q1 		$49.3M Sell
297,288
-240,649
-45% -$37.7M 0.23% 91
2024
Q4 		$77.8M Sell
537,937
-932,184
-63% -$144M 0.36% 52
2024
Q3 		$238M Sell
1,470,121
-1,734,184
-54% -$276M 1.35% 12
2024
Q2 		$468M Buy
3,204,305
+361,072
+13% +$53.7M 2.45% 9
2024
Q1 		$450M Buy
2,843,233
+68,546
+2% +$10.9M 2.27% 7
2023
Q4 		$435M Buy
2,774,687
+50,332
+2% +$7.72M 2.43% 6
2023
Q3 		$424M Sell
2,724,355
-457,073
-14% -$75.4M 2.56% 9
2023
Q2 		$527M Sell
3,181,428
-406,023
-11% -$65.5M 3.25% 4
2023
Q1 		$556M Buy
3,587,451
+19,563
+0.5% +$3.16M 3.39% 4
2022
Q4 		$630M Sell
3,567,888
-1,144,625
-24% -$198M 3.44% 4
2022
Q3 		$770M Buy
4,712,513
+379,880
+9% +$64.3M 3.9% 2
2022
Q2 		$769M Sell
4,332,633
-12,369
-0.3% -$2.2M 3.26% 2
2022
Q1 		$770M Buy
4,345,002
+1,247,260
+40% +$212M 3.1% 7
2021
Q4 		$530M Buy
3,097,742
+343,706
+12% +$56.3M 3.08% 5
2021
Q3 		$445M Sell
2,754,036
-69,070
-2% -$11.8M 2.44% 8
2021
Q2 		$465M Buy
2,823,106
+1,113,211
+65% +$184M 2.98% 5
2021
Q1 		$281M Buy
1,709,895
+240,126
+16% +$38.9M 2.48% 7
2020
Q4 		$231M Buy
1,469,769
+804,367
+121% +$119M 2% 12
2020
Q3 		$99.1M Buy
+665,402
New +$98.5M 1.19% 19
2020
Q2 		– Sell
-8,215
Closed -$1.08M – 452
2020
Q1 		$1.08M Buy
+8,215
New +$1.17M 0.02% 193
2018
Q4 		– Sell
-77,815
Closed -$10.8M – 496
2018
Q3 		$10.8M Sell
77,815
-32,135
-29% -$4.27M 0.11% 70
2018
Q2 		$13.3M Buy
+109,950
New +$13.7M 0.13% 63
2016
Q4 		– Sell
-44,400
Closed -$5.25M – 312
2016
Q3 		$5.25M Sell
44,400
-85,300
-66% -$10.3M 0.05% 119
2016
Q2 		$15.7M Buy
+129,700
New +$14.7M 0.2% 31
2016
Q1 		– Sell
-109,693
Closed -$11.3M – 287
2015
Q4 		$11.3M Sell
109,693
-57,900
-35% -$5.82M 0.15% 53
2015
Q3 		$15.6M Sell
167,593
-27,400
-14% -$2.65M 0.21% 37
2015
Q2 		$19M Sell
194,993
-73,100
-27% -$7.32M 0.18% 12
2015
Q1 		$27M Buy
268,093
+203,800
+317% +$20.7M 0.21% 8
2014
Q4 		$6.72M Sell
64,293
-19,900
-24% -$2.1M 0.05% 85
2014
Q3 		$8.97M Buy
84,193
+18,300
+28% +$1.9M 0.07% 49
2014
Q2 		$6.89M Sell
65,893
-197,100
-75% -$19.9M 0.05% 79
2014
Q1 		$25.8M Buy
262,993
+149,800
+132% +$13.9M 0.21% 9
2013
Q4 		$10.4M Buy
113,193
+85,900
+315% +$7.92M 0.08% 48
2013
Q3 		$2.37M Buy
+27,293
New +$2.45M 0.02% 155

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bridgewater Associates's JNJ Position: Q1 2026 in Review

Bridgewater Associates reduced its Johnson & Johnson (JNJ) stake by 47% in Q1 2026, selling an estimated $144M and leaving 696,884 shares worth $170M. The position accounts for 0.76% of the portfolio, ranked #18.

Bridgewater Associates first reported a position in JNJ in Q3 2013 and has held it in 38 quarters since. The position peaked at $770M in Q1 2022. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Bridgewater Associates held 696,884 shares of Johnson & Johnson worth $170M as of Q1 2026.
  • Bridgewater Associates sold 617,074 Johnson & Johnson shares in Q1 2026, an estimated $144M.
  • Johnson & Johnson made up 0.76% of Bridgewater Associates's portfolio in Q1 2026, its #18 holding.
  • Bridgewater Associates first reported a position in Johnson & Johnson in Q3 2013 and has held it in 38 quarters since.
  • Bridgewater Associates's Johnson & Johnson position peaked at $770M in Q1 2022.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.